Piramal Announces Brand Association for Naturolax-A® with actor Subodh Bhave
Naturolax-A® has provided Indian consumers effective relief from constipation
Mumbai, India | August 16, 2021: Piramal Pharma Limited’s Consumer Products Division today announced its association with leading actor Subodh Bhave for its ayurvedic product Naturolax-A®. Naturolax-A® is an ayurvedic formula that comes in a tasty orange flavor with high effervescence providing effective relief from constipation.
Over the past few years, Indian dietary habits have changed gradually and increasing dependence on junk food, irregular food habits, and sedentary lifestyles have increased digestive problems. With Naturolax-A®, the aim is to offer an effective remedy to constipation.
On this association, Nitish Bajaj, CEO, India Consumer Product’s Division, Piramal Pharma Limited said that “We are pleased to associate with Subodh Bhave, a popular Indian actor, writer, producer, and director who is very well known for his work in Marathi Cinema and is loved by many consumers in Maharashtra. Our aim is to build Naturolax-A® as a preferred solution for consumers to solve their constipation issues.”
Speaking on his association with Naturolax-A® actor Subodh Bhave said, “I am thrilled to be associated with Piramal Pharma’s Naturolax-A. It is a trusted brand that provides relief to many consumers and helps them to solve their constipation problems”
About Piramal India Consumer Products Division:
Piramal Pharma’s India Consumer Products Division’s portfolio comprises 21 brands with offerings spanning multiple categories. It aims to be among the top three over-the-counter (OTC) product companies in India. Over the last two years, the business has invested significantly in various growth levers. The Company’s strategy of expanding the product portfolio and distribution network has worked well and the Consumer Products business is evolving into a strong player in India’s OTC market. For more information visit: Piramal Pharma Limited – Consumer Products Division
About Piramal Pharma Limited:
Piramal Pharma Limited (PPL), a subsidiary of Piramal Enterprises Limited, offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 14 global facilities and a global distribution network in over 100 countries. PPL includes an integrated contract development and manufacturing (CDMO) business, Complex hospital generics business, and India Consumer Products business, selling over-the-counter products in India. In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.